Market Access EMA’s strategy for speeding up drug approvals in the EU The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike
Digital Power of digital technology and partnership to accelerate de... We are living through the fastest period of digital growth in human history. New technologies are transforming how we live, work, connect and innovate.
Sales & Marketing Balancing interests in launching medicines Launching new medicine at the right price is a complex issue, requiring a balance of interests
Market Access Innovative Medicines Fund and the opportunity for ICSs-indus... In June 2022, NHS England (NHSE) and the National Institute for Health and Care Excellence (NICE) launched the Innovative Medicines Fund (IMF).
R&D Modelling biologics: Challenges and opportunities, with Dr D... From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.